CN Patent

CN102574894A — 稳定化的黑皮质素配体

Assigned to ZHANG LI CONTROL CO Ltd · Expires 2012-07-11 · 14y expired

What this patent protects

本发明公开了用于非-天然存在的黑皮质素配体的组合物和方法，包括偶联于耐降解的C-端延伸(及任选地，N-端延伸)的黑皮质素类似物，以产生具有减小的或消除的心血管活性而保留期望的黑皮质素调控活性的稳定的黑皮质素配体。

USPTO Abstract

本发明公开了用于非-天然存在的黑皮质素配体的组合物和方法，包括偶联于耐降解的C-端延伸(及任选地，N-端延伸)的黑皮质素类似物，以产生具有减小的或消除的心血管活性而保留期望的黑皮质素调控活性的稳定的黑皮质素配体。

Drugs covered by this patent

Patent Metadata

Patent number
CN102574894A
Jurisdiction
CN
Classification
—
Expires
2012-07-11
Drug substance claim
No
Drug product claim
No
Assignee
ZHANG LI CONTROL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.